Company Performance - VALE S.A. experienced a decline of 4.79% in its stock price, closing at $9.35, which was a larger drop compared to the S&P 500's loss of 0.84% [1] - Over the past month, VALE's shares gained 0.2%, outperforming the Basic Materials sector, which remained flat, but lagging behind the S&P 500's gain of 1.44% [1] Upcoming Earnings - The upcoming earnings disclosure for VALE S.A. is anticipated to report an EPS of $0.44, reflecting a 2.33% increase from the same quarter last year [2] - Revenue is expected to reach $10 billion, indicating a 0.78% increase compared to the previous year [2] Full Year Projections - For the full year, Zacks Consensus Estimates project earnings of $1.78 per share and revenue of $39.39 billion, representing a decrease of 2.2% in earnings and an increase of 3.5% in revenue from the prior year [3] Analyst Estimates - Recent adjustments to analyst estimates for VALE S.A. are important as they reflect changes in short-term business dynamics, with upward revisions indicating positive sentiment towards the company's operations [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks VALE S.A. at 3 (Hold) [6] Valuation Metrics - VALE S.A. has a Forward P/E ratio of 5.52, which is in line with the industry average [7] - The company also has a PEG ratio of 0.32, matching the average for the Mining - Iron industry, which is part of the Basic Materials sector [8] Industry Ranking - The Mining - Iron industry holds a Zacks Industry Rank of 93, placing it in the top 38% of over 250 industries [8] - Research indicates that industries in the top 50% outperform those in the bottom half by a factor of 2 to 1 [9]

Company Performance - Hologic (HOLX) closed at $64.14, reflecting a -1.6% change from the previous day, underperforming the S&P 500's daily loss of 0.84% [1] - Over the past month, Hologic's shares have increased by 14.77%, while the Medical sector remained flat at 0% and the S&P 500 gained 1.44% [1] Earnings Expectations - Hologic is expected to report an EPS of $1.06, unchanged from the prior-year quarter, with a revenue estimate of $1.01 billion, indicating a 0.39% decrease from the same quarter last year [2] - Full-year Zacks Consensus Estimates project earnings of $4.2 per share and revenue of $4.08 billion, representing year-over-year changes of +2.94% and +1.16%, respectively [3] Analyst Estimates and Valuation - Recent changes in analyst estimates for Hologic are crucial, as positive revisions often indicate a favorable business outlook [3] - Hologic currently has a Zacks Rank of 4 (Sell), with a Forward P/E ratio of 15.52, which is a discount compared to the industry average Forward P/E of 26.88 [5] - The PEG ratio for Hologic stands at 2.39, compared to the Medical - Instruments industry average of 2.26 [6] Industry Context - The Medical - Instruments industry is ranked 151 in the Zacks Industry Rank, placing it in the bottom 39% of over 250 industries [6] - The Zacks Rank system indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks. ...

Company Performance - Clearway Energy (CWEN) closed at $32.22, reflecting a +1.93% change from the previous day's closing price, outperforming the S&P 500's gain of 0.94% [1] - Prior to the recent trading session, CWEN shares had increased by 4.12%, lagging behind the Oils-Energy sector's gain of 4.54% but outperforming the S&P 500's gain of 1.67% [2] Upcoming Earnings - The upcoming earnings per share (EPS) for Clearway Energy is projected at $0.7, indicating a significant 62.79% increase compared to the same quarter of the previous year [3] - Quarterly revenue is expected to reach $445.36 million, which represents a 21.68% increase from the year-ago period [3] - Full-year Zacks Consensus Estimates predict earnings of $1.1 per share and revenue of $1.5 billion, reflecting year-over-year changes of +46.67% and +9.61%, respectively [4] Analyst Sentiment - Recent revisions to analyst forecasts for Clearway Energy are crucial as they often indicate shifting business dynamics, with positive revisions suggesting analyst optimism about the company's profitability [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Clearway Energy at 3 (Hold), with no changes in the EPS estimate over the past month [6] Valuation Metrics - Clearway Energy has a Forward P/E ratio of 28.79, indicating a premium compared to its industry's Forward P/E of 19.74 [7] - The company has a PEG ratio of 0.75, significantly lower than the average PEG ratio of 2.23 for the Alternative Energy - Other industry [7] Industry Context - The Alternative Energy - Other industry, part of the Oils-Energy sector, holds a Zacks Industry Rank of 180, placing it in the bottom 27% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

T. Rowe Price (TROW) closed at $93.21 in the latest trading session, marking a +1.78% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.94%. At the same time, the Dow added 0.75%, and the tech-heavy Nasdaq gained 1.52%. Coming into today, shares of the financial services firm had lost 6.61% in the past month. In that same time, the Finance sector lost 0.56%, while the S&P 500 gained 1.67%. The investment community will be closely monitoring the performance of T. ...

Company Performance - Modine's stock closed at $95.85, reflecting a gain of +2.27% from the previous trading session, outperforming the S&P 500's gain of 0.94% [1] - Over the past month, Modine's shares have decreased by 10.34%, which is significantly worse than the Auto-Tires-Trucks sector's loss of 3.9% and the S&P 500's gain of 1.67% [1] Upcoming Earnings - Analysts expect Modine to report an EPS of $0.98, indicating a decline of 5.77% compared to the same quarter last year [2] - Revenue is anticipated to be $654.07 million, down 1.12% from the prior-year quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $4.51 per share, representing an increase of +11.36% from the previous year, while revenue is expected to reach $2.73 billion, up +5.77% [3] - Recent revisions to analyst forecasts are crucial as they reflect short-term business trends, with positive changes indicating analyst optimism [3] Valuation Metrics - Modine's current Forward P/E ratio is 20.76, which is a premium compared to the industry average of 12.34 [6] - The company has a PEG ratio of 0.61, lower than the industry average PEG ratio of 1.28 [6] Industry Context - Modine operates within the Automotive - Original Equipment industry, which has a Zacks Industry Rank of 137, placing it in the bottom 45% of over 250 industries [7] - The performance of individual industry groups is measured by the Zacks Industry Rank, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emp ...

Group 1: Company Performance - Coterra Energy (CTRA) closed at $26.70, with a +2.14% increase from the previous day, outperforming the S&P 500's daily loss of 1.13% [1] - The company has gained 5.87% in the past month, while the Oils-Energy sector gained 5.03% and the S&P 500 gained 3.55% [1] - The forecasted EPS for the upcoming release is $0.51, reflecting a 37.84% increase from the same quarter last year, with expected revenue of $1.76 billion, indicating a 38.54% growth [2] Group 2: Annual Estimates - For the annual period, earnings are anticipated to be $2.59 per share and revenue is expected to be $7.59 billion, representing increases of +54.17% and +39.14% respectively from the previous year [3] - Recent changes to analyst estimates indicate positive revisions, suggesting analysts' confidence in the company's performance and profit potential [3] Group 3: Valuation Metrics - Coterra Energy has a Forward P/E ratio of 10.11, which is lower than the industry's Forward P/E of 11.19, indicating a valuation discount [6] - The company has a PEG ratio of 0.35, significantly lower than the average PEG ratio of 2.55 for the Oil and Gas - Exploration and Production - United States industry [7] Group 4: Industry Context - The Oil and Gas - Exploration and Production - United States industry is part of the Oils-Energy sector and currently holds a Zacks Industry Rank of 172, placing it in the bottom 31% of over 250 industries [8] - The Zacks Industry Rank assesses the strength of industry groups, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [8]

Boston Scientific (BSX) closed at $99.74 in the latest trading session, marking a +1.2% move from the prior day. The stock outpaced the S&P 500's daily loss of 1.13%. On the other hand, the Dow registered a loss of 1.79%, and the technology-centric Nasdaq decreased by 1.3%. The medical device manufacturer's shares have seen a decrease of 6.01% over the last month, not keeping up with the Medical sector's gain of 3.07% and the S&P 500's gain of 3.55%.The upcoming earnings release of Boston Scientific will be ...

Camtek (CAMT) closed the most recent trading day at $70.33, moving -4.23% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 1.13%. At the same time, the Dow lost 1.79%, and the tech-heavy Nasdaq lost 1.3%. Prior to today's trading, shares of the maker of automatic optical inspection and process enhancement systems had gained 10.42% outpaced the Computer and Technology sector's gain of 7.36% and the S&P 500's gain of 3.55%.The investment community will be payi ...